6/13
07:09 am
mtnb
Matinas BioPharma's Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin [Yahoo! Finance]
Medium
Report
Matinas BioPharma's Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin [Yahoo! Finance]
6/13
07:00 am
mtnb
Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin
Medium
Report
Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin
5/16
07:06 am
mtnb
New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 [Yahoo! Finance]
Low
Report
New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 [Yahoo! Finance]
5/16
07:00 am
mtnb
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
Low
Report
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
5/9
04:12 pm
mtnb
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
Low
Report
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
5/9
04:05 pm
mtnb
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
Low
Report
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
5/7
08:00 am
mtnb
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting
Medium
Report
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting
5/2
07:00 am
mtnb
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
Low
Report
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
5/9
04:09 pm
mtnb
Form 8-K Matinas BioPharma Holdin For: May 09
Low
Report
Form 8-K Matinas BioPharma Holdin For: May 09
5/9
04:02 pm
mtnb
Form 10-Q Matinas BioPharma Holdin For: Mar 31
Low
Report
Form 10-Q Matinas BioPharma Holdin For: Mar 31
4/5
07:00 am
mtnb
Form 8-K Matinas BioPharma Holdin For: Apr 02
Medium
Report
Form 8-K Matinas BioPharma Holdin For: Apr 02
4/4
04:16 pm
mtnb
Form 424B5 Matinas BioPharma Holdin
Low
Report
Form 424B5 Matinas BioPharma Holdin
3/28
09:01 am
mtnb
Form 8-K Matinas BioPharma Holdin For: Mar 28
Medium
Report
Form 8-K Matinas BioPharma Holdin For: Mar 28
3/27
04:22 pm
mtnb
Form 8-K Matinas BioPharma Holdin For: Mar 27
Medium
Report
Form 8-K Matinas BioPharma Holdin For: Mar 27
3/27
04:02 pm
mtnb
Form 10-K Matinas BioPharma Holdin For: Dec 31
Medium
Report
Form 10-K Matinas BioPharma Holdin For: Dec 31
3/25
08:06 am
mtnb
Form 8-K Matinas BioPharma Holdin For: Mar 25
Medium
Report
Form 8-K Matinas BioPharma Holdin For: Mar 25
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register